Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
58 hedge funds and large institutions have $154M invested in Akoya BioSciences in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
53% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 15
7% more funds holding
Funds holding: 54 → 58 (+4)
3.42% more ownership
Funds ownership: 34.54% → 37.96% (+3.4%)
2% more capital invested
Capital invested by funds: $150M → $154M (+$3.63M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HEC
Hudson Executive Capital
New York
|
+$16.5M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.85M |
| 3 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$3.34M |
| 4 |
RI
RTW Investments
New York
|
+$3.3M |
| 5 |
BlackRock
New York
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$10.5M |
| 2 |
Millennium Management
New York
|
-$6.29M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.46M |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$938K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$560K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Wells Fargo
San Francisco,
California
| $8K | -$4.6K | -349 | -32% |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | +$1.36K | +103 | +25% |
|
53
Citigroup
New York
| $3K | -$10.2K | -771 | -75% |
|
54
Osaic Holdings
Scottsdale,
Arizona
| $3K | -$250 | -19 | -6% |
|
|
GWS
55
Glassman Wealth Services
Vienna,
Virginia
| $1K | +$869 | +66 | New |
|
|
CS
56
Credit Suisse
Zurich,
Switzerland
| $1K | +$896 | +68 | +340% |
|
|
57
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
| – | -$938K | -72,994 | Closed |
|
|
PAMP
58
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$419K | -32,581 | Closed |
|
59
Citadel Advisors
Miami,
Florida
| – | -$363K | -28,230 | Closed |
|
60
AllianceBernstein
Nashville,
Tennessee
| – | -$202K | -15,709 | Closed |
|
61
UBS Group
Zurich,
Switzerland
| – | -$11K | -844 | Closed |
|
|
BTI
62
Blue Trust Inc
Alpharetta,
Georgia
| – | +$382 | +29 | New |
|
AKYA Hedge Fund Activity: Q3 2022 in Review
58 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2022, worth a combined $154M — up 2.4% from $150M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AKYA positions and 5 closed out — a net gain of 4 holders — while 23 added to existing stakes and 15 trimmed.
The largest buyer was Hudson Executive Capital, adding an estimated $16.5M. The largest seller was Board of Trustees of The Leland Stanford Junior University, cutting an estimated $10.5M.
- 58 institutional investors held Akoya BioSciences (AKYA) as of Q3 2022, up from 54 in Q2 2022.
- Funds reported $154M of Akoya BioSciences stock for Q3 2022, up 2.4% quarter-over-quarter.
- 9 funds opened new Akoya BioSciences positions in Q3 2022 and 5 closed out, a net change of +4 holders.
- The largest Akoya BioSciences buyer in Q3 2022 was Hudson Executive Capital, an estimated $16.5M added.
- The largest Akoya BioSciences seller in Q3 2022 was Board of Trustees of The Leland Stanford Junior University, an estimated $10.5M sold.
Based on aggregated 13F filings for Q3 2022.